Veterinary Medicines

PARVOSUIN-MR/AD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Authorised
  • Aujeszky's disease virus, strain Bartha K61, Live
  • Porcine parvovirus, strain NADL-2, Inactivated
  • Erysipelothrix rhusiopathiae, Inactivated
Download as PDF

Product identification

Medicine name:
PARVOSUIN-MR/AD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
  • Aujeszky's disease virus, strain Bartha K61, Live
  • Porcine parvovirus, strain NADL-2, Inactivated
  • Erysipelothrix rhusiopathiae, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Aujeszky's disease virus, strain Bartha K61, Live
    0.26
    gram(s)
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain NADL-2, Inactivated
    0.26
    gram(s)
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, Inactivated
    0.28
    gram(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 95615/20-10-2021/K-0093201
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 14/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 14/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."